成大藥業股份有限公司 - 資產負債表 (Quarterly)

成大藥業股份有限公司
CN ˙ SZSE
¥34.86 ↑1.26 (3.75%)
2026-06-03
分享價格
資產負債表 (Quarterly)

成大藥業股份有限公司資產負債表反映公司在特定時間點的帳戶餘額。財務狀況表數據包括資產、流動資產、固定資產、不動產、廠房和設備(PPE)、存貨、無形資產、負債、流動負債、長期負債、融資租賃負債、普通股、保留盈利、庫存股和股東權益。

除以每股為單位的數字外,所有數字為1,000,000.00倍數。

2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
現金 18 742 504 442 604 1,413 1,415 1,413 1,364 1,203 942 479 178 445 819 806 726 431
改變 (%) 3,910.47 -32.06 -12.30 36.78 133.77 0.12 -0.11 -3.47 -11.81 -21.66 -49.16 -62.75 149.63 83.75 -1.57 -9.92 -40.60
流動資產 226 1,770 1,740 1,751 1,680 1,684 1,686 1,683 1,643 1,569 1,518 1,463 1,415 1,409 1,419 1,296 1,304 1,301
改變 (%) 683.29 -1.70 0.64 -4.06 0.28 0.11 -0.22 -2.36 -4.51 -3.23 -3.61 -3.28 -0.42 0.71 -8.71 0.67 -0.25
資產 683 2,261 2,256 2,289 2,322 2,356 2,370 2,391 2,455 2,404 2,407 2,395 2,436 2,389 2,409 2,369 2,350 2,332
改變 (%) 230.89 -0.20 1.46 1.42 1.46 0.59 0.92 2.67 -2.10 0.13 -0.48 1.71 -1.93 0.80 -1.66 -0.79 -0.75
負債 153 83 83 89 106 120 153 143 176 158 158 162 291 245 250 236 253 228
改變 (%) -45.90 -0.00 7.15 19.07 13.36 27.45 -6.76 23.76 -10.52 -0.14 3.02 79.07 -15.71 1.99 -5.44 6.96 -9.77
公平 530 2,178 2,173 2,200 2,216 2,236 2,217 2,249 2,279 2,246 2,249 2,233 2,146 2,144 2,159 2,132 2,097 2,104
改變 (%) 310.96 -0.20 1.24 0.71 0.89 -0.85 1.45 1.33 -1.45 0.15 -0.72 -3.91 -0.06 0.67 -1.23 -1.65 0.33
負債和股本 683 2,261 2,256 2,289 2,322 2,356 2,370 2,391 2,455 2,404 2,407 2,395 2,436 2,389 2,409 2,369 2,350 2,332
改變 (%) 230.89 -0.20 1.46 1.42 1.46 0.59 0.92 2.67 -2.10 0.13 -0.48 1.71 -1.93 0.80 -1.66 -0.79 -0.75

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista